Nick Leschly's most recent trade in 2seventy bio Inc was a trade of 897,642 Common Stock done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 2seventy bio Inc | Nick Leschly | Director | 13 May 2025 | 897,642 | 0 | - | - | Common Stock | ||
| 2seventy bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 469,000 | 0 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 335,964 | 897,642 | - | - | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director | 13 May 2025 | 41,000 | 0 | - | - | Common Stock | ||
| 2seventy bio Inc | Nick Leschly | Director | 13 May 2025 | 15,233 | 0 | - | - | Common Stock | ||
| 2seventy bio Inc | Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 03 Jan 2025 | 85,978 | 1,234,498 | - | 2.9 | 252,423 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 03 Jan 2025 | 892 | 1,233,606 | - | 2.8 | 2,478 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 315,839 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 469,000 | 469,000 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 235,000 | 1,320,476 | - | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.75 per share. | 05 Jan 2024 | 1,554 | 1,085,476 | - | 3.8 | 5,833 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 03 Jan 2024 | 72,312 | 1,087,030 | - | 3.9 | 279,739 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.49 per share. | 22 Aug 2023 | 9,312 | 1,159,342 | - | 5.5 | 51,090 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 03 Aug 2023 | 9,060 | 1,168,654 | - | 6.1 | 55,499 | Common Stock |
| Synlogic Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 290,939 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 428,571 | 1,044,214 | - | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 162,500 | 162,500 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 81,250 | 615,643 | - | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.46 per share. | 12 Jan 2023 | 6,587 | 536,419 | - | 10.5 | 68,889 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 11 Jan 2023 | 4,290 | 280,149 (0%) | 0% | 7.8 | 33,480 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 11 Jan 2023 | 2,026 | 534,393 | - | 10.6 | 21,533 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 09 Jan 2023 | 2,979 | 543,006 | - | 10.3 | 30,787 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.23 per share. | 05 Aug 2022 | 5,499 | 545,985 | - | 16.2 | 89,263 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.81 per share. | 15 Jul 2022 | 5,404 | 551,484 | - | 13.8 | 74,629 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,109 | 284,439 (0%) | 0% | 0 | Common Stock | |
| Synlogic Inc | Nick Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 12.20 per share. | 17 Mar 2022 | 368,857 | 556,888 | - | 12.2 | 4,500,055 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 267,000 | 267,000 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 133,500 | 690,388 | - | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 10 Jan 2022 | 5,068 | 281,330 (0%) | 0% | 9.6 | 48,869 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 10 Jan 2022 | 2,369 | 286,398 (0%) | 0% | 9.4 | 22,274 | Common Stock |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.91 per share. | 07 Jan 2022 | 3,270 | 188,031 | - | 23.9 | 78,179 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 165,000 | 162,450 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 165,000 | 162,450 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 120,000 | 118,145 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 110,000 | 108,300 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 100,000 | 98,454 | - | - | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 90,000 | 0 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 90,000 | 88,609 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 65,000 | 63,995 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 57,957 | 57,957 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 54,149 | 54,149 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 54,149 | 54,149 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 50,425 | 191,301 | - | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 39,381 | 39,381 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 36,099 | 36,099 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 33,038 | 59,191 | - | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 32,817 | 32,817 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 29,535 | 29,535 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 23,998 | 288,005 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 21,331 | 21,331 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 12,306 | 264,007 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 11,591 | 26,153 | - | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 7,999 | 14,562 | - | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 251,701 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 4,102 | 6,563 | - | 0 | Common Stock | |
| 2seventy bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 2,461 | 2,461 | - | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 51,304 | 357,996 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 51,303 | 409,299 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2021 | 123,000 | 123,000 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2021 | 123,000 | 45,699 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 03 May 2021 | 444 | 306,692 (0%) | 0% | 30.2 | 13,387 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.20 per share. | 05 Apr 2021 | 444 | 307,136 (0%) | 0% | 30.2 | 13,411 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 203,355 | 0 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 04 Mar 2021 | 203,355 | 307,580 (0%) | 0% | 5.5 | 1,118,534 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 29.58 per share. | 02 Mar 2021 | 444 | 104,225 (0%) | 0% | 29.6 | 13,134 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 18,000 | 104,669 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.93 per share. | 02 Feb 2021 | 594 | 86,669 (0%) | 0% | 45.9 | 27,280 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 05 Jan 2021 | 5,873 | 91,485 (0%) | 0% | 44.8 | 262,867 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 05 Jan 2021 | 4,222 | 87,263 (0%) | 0% | 45.5 | 191,947 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.95 per share. | 05 Jan 2021 | 333 | 97,358 (0%) | 0% | 45.0 | 14,969 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 02 Dec 2020 | 430 | 97,705 (0%) | 0% | 46.2 | 19,861 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 02 Dec 2020 | 14 | 97,691 (0%) | 0% | 46.5 | 651 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.51 per share. | 02 Nov 2020 | 319 | 98,260 (0%) | 0% | 52.5 | 16,750 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 53.82 per share. | 02 Nov 2020 | 80 | 98,180 (0%) | 0% | 53.8 | 4,306 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 54.44 per share. | 02 Nov 2020 | 45 | 98,135 (0%) | 0% | 54.4 | 2,450 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.76 per share. | 02 Oct 2020 | 450 | 98,579 (0%) | 0% | 52.8 | 23,744 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 58.60 per share. | 03 Sep 2020 | 431 | 99,029 (0%) | 0% | 58.6 | 25,257 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 60.32 per share. | 03 Aug 2020 | 332 | 99,572 (0%) | 0% | 60.3 | 20,026 | Common Stock |
| Bluebird bio Inc | Nick Leschly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 60.98 per share. | 03 Aug 2020 | 112 | 99,460 (0%) | 0% | 61.0 | 6,830 | Common Stock |